SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-138385
Filing Date
2020-12-22
Accepted
2020-12-22 09:08:18
Documents
15
Period of Report
2020-12-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2039126d1_8k.htm   iXBRL 8-K 26560
2 EXHIBIT 99.1 tm2039126d1_ex99-1.htm EX-99.1 16439
6 GRAPHIC tm2039126d1_ex99-1img001.jpg GRAPHIC 3488
7 GRAPHIC tm2039126d1_ex99-1img002.jpg GRAPHIC 4488
  Complete submission text file 0001104659-20-138385.txt   232261

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20201222.xsd EX-101.SCH 3196
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20201222_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20201222_pre.xml EX-101.PRE 22717
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2039126d1_8k_htm.xml XML 3494
Mailing Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355
Business Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 484-328-4698
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 201406287
SIC: 2836 Biological Products, (No Diagnostic Substances)